Effect of partial gastrectomy on serum anti-Helicobacter pylori immunoglobulins in peptic ulcer patients.
Since biliary enterogastric reflux is suggested to eradicate gastric infection with Helicobacter pylori (HP), we have investigated in a prospective randomized study the effect of partial gastrectomy with either Billroth II or Roux-en-Y anastomosis on infection with HP as assessed by the titers of IgG and IgA antibodies against HP in serum. These antibodies were measured by ELISA in serum of 22 patients before and at 10 days and 6, 15, and 24 months after either Billroth II (N = 11) or Roux-en-Y (N = 11) gastrectomy for peptic ulcer. All patients had HP demonstrated in their preoperative endoscopic gastric biopsies. The preoperative serum IgA antibodies against HP (anti-HP IgA) were increased in 20 of the 22 patients (range 0.21-1.69) while the IgG antibodies (anti-HP IgG) were increased in all 22 patients (range 0.38-1.31). Four of the Billroth II patients had clearance of HP from gastric biopsies accompanied by rapid and pronounced decrease of anti-HP IgA. In contrast, the patients with Roux-en-Y gastrectomy and the Billroth II patients with persistent HP infection had no change in anti-HP IgA after surgery. Anti-HP IgG showed variable results in the four patients without gastric HP infection and was not affected by gastrectomy in the patients with persistent HP infection. We concluded that serum anti-HP IgA, but not anti-HP IgG, is helpful in identifying those patients in whom HP is no longer demonstrable after Billroth II gastrectomy. Gastrectomy with Roux-en-Y anastomosis had no effect on gastric HP infection.
Lamers
C B
CB
Department of Gastroenterology-Hepatology, University Hospital, Leiden, The Netherlands.
Rieu
P N
PN
Veenendaal
R A
RA
van Duijn
W
W
Offerhaus
G J
GJ
Joosten
H J
HJ
Peña
A S
AS
D000907:Antibodies, Bacterial / Q000032:analysis*; D005260:Female; D005743:Gastrectomy / Q000379:methods; D016481:Helicobacter Infections / Q000276:immunology / Q000601:surgery; D016480:Helicobacter pylori / Q000276:immunology*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis*; D007074:Immunoglobulin G / Q000032:analysis*; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000276:immunology / Q000382:microbiology / Q000601:surgery*; D011446:Prospective Studies
D000907:Antibodies, Bacterial; D007070:Immunoglobulin A; D007074:Immunoglobulin G